VC Firm OrbiMed Advisors Raises $325 Million For Second Asia Healthcare Fund

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OrbiMed Advisors has secured $325 million to fund health-care companies in Asian nations such as China and India, where rising affluence is fueling increased demand for medical products and services.

The New York firm set out to raise $300 million for OrbiMed Asia Partners II LP in the first quarter of 2013. The new partnership, which closed over the summer, is a jump from the $182 million OrbiMed raised for its debut Asia fund in 2008.

Help employers find you! Check out all the jobs and post your resume.

Back to news